Canaccord Genuity Slashes PT on Enovis Corporation (ENOV) to $50 From $58

Enovis Corporation (NYSE:ENOV) is one of the best small cap stocks to buy with huge upside potential. Canaccord Genuity slashed the price target on Enovis Corporation (NYSE:ENOV) to $50 from $58 on December 17 and maintained a Buy rating on the stock. The firm updated its model on the company to take into account its new 2027 estimates, with some updates to its 2026 estimates as well.

In addition, Enovis Corporation (NYSE:ENOV) was initiated with a Buy rating by Freedom Capital analyst Keith Hinton on December 16, who set a $45 price target on the stock. The analyst told investors that the orthopedics-focused medtech company is undergoing a rebound in organic growth in 2025, and the momentum is expected to continue.

He views the company’s improving competitive positioning to be “underappreciated”, with shares trading near their post-spin lows and reducing M&A dyssynergies diminishing. Hinton anticipates the multiple to begin bridging the gap with peers, provided the new CEO continues execution.

Separately, in its fiscal Q3 2025 results, Enovis Corporation (NYSE:ENOV) reported that its net sales for the quarter rose 9% on a reported basis and 7% on an organic basis to $549 million compared to the same quarter last year, with the quarterly results reflecting stable end markets, encouraging momentum in new product introductions, and continued execution in P&R and Recon. Net sales in Recon rose 2% on a reported basis and 9% on an organic basis compared to the prior year period, and P&R grew 6% on a reported basis and 4% on an organic basis.

Enovis Corporation (NYSE:ENOV) is a medical technology growth company that develops clinically differentiated solutions to transform workflows and generate better patient outcomes. The company operates through the Prevention & Recovery and Reconstructive segments.

While we acknowledge the potential of XXXX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than XXXX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.